Dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2) as a novel marker in T1 high-grade and T2 bladder cancer patients receiving neoadjuvant chemotherapy: DYRK2 is associated with survival in bladder cancer

BACKGROUND: To investigate associations between dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2) expression and survival in T1 high-grade or T2 bladder cancer patients treated with neoadjuvant chemotherapy. METHODS: The cohort under investigation comprised 44 patients who underwe...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Urol
Asıl Yazarlar: Nomura, Shunichiro, Suzuki, Yasutomo, Takahashi, Ryo, Terasaki, Mika, Kimata, Ryoji, Terasaki, Yasuhiro, Hamasaki, Tsutomu, Kimura, Go, Shimizu, Akira, Kondo, Yukihiro
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2015
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4472248/
https://ncbi.nlm.nih.gov/pubmed/26087959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-015-0040-7
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller